NCT02182531View on ClinicalTrials.gov

Epinastine and Pseudoephedrine Fixed Combination Compared to Separate Administration in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 1999

Primary Completion Date

October 31, 1999

Conditions
Healthy
Interventions
DRUG

Epinastine

DRUG

Pseudoephedrine

DRUG

Epinastine + Pseudoephedrine combination

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY